Back
Brighthouse Financial Vs. Kymera Therapeutics Industry Stock Comparison
Sell
37
BHF
Brighthouse Financial
Last Price:
$58.84
Seasonality Move:
3.43%
Buy
77
KYMR
Kymera Therapeutics
Last Price:
$45.92
Seasonality Move:
30.84%
Sell
37
Brighthouse Financial (BHF)
is a Sell
Is Brighthouse Financial a Buy, Sell or Hold?
-
The current Brighthouse Financial [BHF] share price is $58.86. The Score for BHF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
BHF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $45.87. The Score for KYMR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BHF Stock Price Chart
What is Brighthouse Financial's stock price today?
-
The Brighthouse Financial share price today is $58.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BHF is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $45.87The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
BHF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 52.71 | Buy |
Chaikin Money Flow: | -682833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.79 - 60.07) | Sell |
Bollinger Bands (100): | (53.52 - 60.8) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.05 | Buy |
Relative Strength Index (14 RSI): | 67.57 | Buy |
Chaikin Money Flow: | 251231 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.82 - 47.48) | Buy |
Bollinger Bands (100): | (27.31 - 40.79) | Buy |
BHF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.01 | Buy |
20-day SMA: | 58.6 | Buy |
50-day SMA: | 56.81 | Buy |
200-day SMA: | 52.42 | Buy |
8-day EMA: | 58.39 | Buy |
20-day EMA: | 58.39 | Buy |
50-day EMA: | 57.6 | Buy |
200-day EMA: | 53.71 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.09 | Sell |
20-day SMA: | 41.33 | Buy |
50-day SMA: | 34.42 | Buy |
200-day SMA: | 39.62 | Buy |
8-day EMA: | 46.1 | Sell |
20-day EMA: | 42.54 | Buy |
50-day EMA: | 37.49 | Buy |
200-day EMA: | 36.91 | Buy |
Brighthouse Financial Earnings Growth & BHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.47 per share, an increase next quarter of $0.57 per share, a decrease this year of $1.56 per share, and an increase next year of $2.48 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.40 per share.
Brighthouse Financial Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |